November 19, 2018 by Andy Morris and Carter Koen
data, holiday retail sales
Issue 11-19-2018, Opinion
Retailers spend millions of dollars combing through data to help them determine ideal store layouts, merchandise packaging and sales strategies to maximize consumer spending over the holiday season. Real-time data tools promise to give organizations a rapid picture of what’s working and what’s not. But data and numbers don’t tell the full story. In the
November 19, 2018 by Tom Block
dunnhumby, Kroger, Walgreens
Issue 11-19-2018, Opinion
The recent partnership of Kroger and Walgreens caught many industry experts off guard largely because the agreement goes against conventional wisdom of maximizing competitive advantages. With this partnership, Walgreens seems to have diminished its convenience advantage by allowing Kroger to leverage it for their own customer pickups. And Kroger seems to be compromising the exclusiveness
November 5, 2018 by Jerry Cacciotti
A.T. Kearney, health care, Jerry Cacciotti, technology
Issue 11-05-2018, Opinion
Editor’s note: The second in a series of seven articles by A.T. Kearney on the trends that are radically transforming the health sector. There is no question that science is rapidly accelerating the health care opportunities we see in the marketplace. Broader genetics capabilities could mean new services and treatments based on genetic makeup that
November 5, 2018 by Jeffrey Woldt
Doug McMillon, Walmart
Issue 11-05-2018, Opinion, Uncategorized
Despite all the attention that Amazon justifiably receives for the transformational effect it is exerting on mass market retailing, a case can be made that the company that is in the best position to meet the omnichannel needs of consumers over the long term is Walmart. Listening to president and chief executive officer Doug McMillon
October 23, 2018 by Stephanie Kennan
Department of Health and Human Services, Medicaid, Opioid
Issue 10-22-2018
Routine monitoring of medication adherence is one of the Medicaid programs that must be included under a new law passed by Congress in response to the opioid epidemic. The recently passed opioid legislation makes improvements in treatment capacity for Medicaid patients. However, the legislation has significance for the pharmacy industry because it directs the Department
October 22, 2018 by Chain Drug Review
McKesson, NCPA
Issue 10-22-2018, News
BOSTON — McKesson’s RxOwnership team recently partnered with the National Community Pharmacists Association (NCPA) for the ninth year to sponsor its Pharmacy Ownership Workshop, to further advance community pharmacy ownership. The Pharmacy Ownership Workshop took place ahead of the NCPA Annual Convention here earlier this month. According to NCPA, more than 50% of past Pharmacy
October 22, 2018 by Chain Drug Review
annual flu shot
Issue 10-22-2018, News
DEERFIELD, Ill. — The majority of Americans — nearly two-thirds — will get a flu shot this year, according to Walgreens 2018-2019 Flu Season Survey. The study reported that, with missed holiday parties and postponed vacations, last year’s flu season led to loads of FOMO (Fear of Missing Out) as the strain of Influenza A
October 22, 2018 by Evan Gutoff
chain drug retailers, grocery stores, pharmacies
Issue 10-22-2018, Opinion, Uncategorized
Pharmacies and grocery stores are better positioned than doctors to promote healthy behavior and prevent debilitating and costly illnesses. Many executives know this, but it is surprising how many acknowledge they have not done much about it. Don’t believe it? Consider who has more information about people and more opportunity to sway their choices. Doctors
October 22, 2018 by Greg Portell and Abby Klanecky
Gen Z, Millennials
Issue 10-22-2018, Opinion
To address the personal forms of value that tomorrow’s consumers will demand, consumer packaged goods companies need to move from “idle” to “agile.” Chain drug stores are uniquely positioned to help. For the past several years, chain drug stores have staked out territory as close as possible to the consumer. Ubiquitous hyperlocal locations have been
October 22, 2018 by Jeffrey Woldt
Birchbox, FedEx, Kroger, Walgreens Boots Aliance
Issue 10-22-2018, Opinion, Uncategorized
For the better part of a decade, Walgreens Boosts Alliance has been engaged in continually rethinking what a chain drug store means to the consumer, and how the format needs to evolve to remain relevant in an era when digital technology is changing the rules of the game in retailing and health care. That process
October 8, 2018 by Chain Drug Review
CVS-Aetna
Issue 10-08-2018
NEW YORK — As the $70 billion merger between CVS Health and Aetna Inc. draws near, the combined company will create a industry-changing model for health care that is more personal than ever before, according to Larry Merlo, CVS Health’s president and chief executive officer. First announced in December, the mega-deal, which is pending antitrust
October 8, 2018 by Chain Drug Review
NACDS, Patient Right to Know Drug Prices Act, Steven Anderson
Issue 10-08-2018
WASHINGTON — Retail pharmacy advocates applauded the House of Representatives for unanimously passing two bipartisan bills that aim to lower drug costs. The bills — the Patient Right to Know Drug Prices Act and the Know the Lowest Price Act — had originated in the Senate, where each had gained earlier approval. The bills were
October 8, 2018 by Chain Drug Review
Bruce Bodaken, John Standley, Rite Aid
Issue 10-08-2018
CAMP HILL, Pa. — Rite Aid Corp. has changed its corporate governance and recast its board. The company separated the chairman and chief executive officer functions, with director Bruce Bodaken becoming chairman and John Standley remaining CEO. That move, along with the naming of three new independent board members, followed the chain’s failed merger with
October 8, 2018 by Kirk Herweck
Drug Take Back Day
Issue 10-08-2018, Opinion, Uncategorized
On October 27 the Drug Enforcement Agency (DEA) will hold its 14th National Consumer Drug Take-Back Day. The event will be well publicized and will enable the safe and secure disposal of millions of pounds of expired and unneeded prescription medications. On that same day, 175 Americans will die from drug overdoses. A troubling trend